scholarly journals An open-label phase I dose-finding study of APR-246 in hematological malignancies

2016 ◽  
Vol 6 (7) ◽  
pp. e447-e447 ◽  
Author(s):  
S Deneberg ◽  
H Cherif ◽  
V Lazarevic ◽  
P-O Andersson ◽  
M von Euler ◽  
...  
Keyword(s):  
Phase I ◽  
Hematological Malignancies ◽  
Dose Finding ◽  
Open Label ◽  
Finding Study ◽  
Open Label Phase ◽  
Dose Finding Study

A Phase I, Randomized, Open-Label, Parallel-Cohort, Dose-Finding Study of Elacridar (GF120918) and Oral Topotecan in Cancer Patients

2007 ◽  
Vol 13 (11) ◽  
pp. 3276-3285 ◽  
Author(s):  
Isa E.L.M. Kuppens ◽  
Els O. Witteveen ◽  
Roxanne C. Jewell ◽  
Sandra A. Radema ◽  
Elaine M. Paul ◽  
...  
Keyword(s):  
Phase I ◽  
Cancer Patients ◽  
Dose Finding ◽  
Open Label ◽  
Finding Study ◽  
Dose Finding Study ◽  
Oral Topotecan

scholarly journals A Phase I Dose-Finding Study of the Novel Toll-like Receptor 8 Agonist VTX-2337 in Adult Subjects with Advanced Solid Tumors or Lymphoma

2014 ◽  
Vol 20 (14) ◽  
pp. 3683-3691 ◽  
Author(s):  
Donald W. Northfelt ◽  
Ramesh K. Ramanathan ◽  
Peter A. Cohen ◽  
Daniel D. Von Hoff ◽  
Glen J. Weiss ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Dose Finding ◽  
Advanced Solid Tumors ◽  
The Novel ◽  
Toll Like Receptor ◽  
Finding Study ◽  
Dose Finding Study

576 Phase I dose-finding study of the combination of alimta (pemetrexed) and paclitaxel in patients with solid tumors

2003 ◽  
Vol 1 (5) ◽  
pp. S174-S175
Author(s):  
D. Zingel ◽  
C. Bolling ◽  
T. Graefe ◽  
D. Radtke ◽  
J. Latz ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Dose Finding ◽  
Finding Study ◽  
Dose Finding Study
Sign in / Sign up

Export Citation Format

Share Document